Madrigal Pharmaceuticals adopts 2026 Stock Plan for employee equity grants
Madrigal Pharmaceuticals, Inc. has adopted a new 2026 Stock Plan to grant equity awards including stock options, restricted stock, and cash-based awards to officers, employees, directors and consultants. The plan is designed to align employee interests with shareholder value crea
View filing at SEC.gov →